Participants List from Academia
University of Texas at Arlington, USA
Stanford University School of Medicine, USA
Mahidol University, Thailand
Amirkabir University of Technology, Iran
Hamdard University, India
Yeshiva University, USA
University of Macau, China
Monash University, Australia
University of Michigan, Ann Arbor
Universidade Federal do Rio de Janeiro, Brazil
University of Denver, Colorado
University of Toronto, Canada
Zagazig University, Egypt
Banaras Hindu University, India
Taipei Medical University, Taiwan
University di Messina CNISM, Italy
University of Tasmania, Australia
Huazhong University of Science and Technology, China
Sogang University, Korea
University of Edinburgh, UK
Martin-Luther-University Halle-Wittenberg, USA
Universidade de sao paulo, Brazil
Eve University, Turkey
University of Delhi, India
Isfahan University of Technology(IUT), Iran
Taif University, Saudi Arabia
University Medical Center, Netherlands
University of Copenhagen, Denmark
University Paris 13, France
Participants List from Business
Cadila Pharmaceuticals, India
Chemical Works of Gedeon Richter, Hungary
3S-Pharmacological Consultation & Research GmbH, Germany
Royal Brisbane and Women's Hospital, Australia
Psoriasis and Cutaneous Inflammation Research Laboratory, USA
Alcon Laboratories Inc., USA
National Institute for Materials Science (NIMS), Japan
Grup de Recerca de Reumatologia (IRHVH), Spain
Bayer Health Care, Richmond, USA
Crown Bioscience Inc., China
Hammersmith Hospital, London
Van Drie Research LLC, USA
Dr.Reddy's labs, India
Merck Research Laboratories, USA
National Institute of Pharmaceutical Education and Research (NIPER), India
AstraZeneca R&D Boston, USA
Abbott Laboratories, USA
Hutchison MediPharma Limited, China
Sage Bionetworks, USA
Central Drug Research Institute, India
Glenmark Pharmaceuticals, India
National Institute for Interdisciplinary Science & Technology (NIIST) , India
Novartis Campus, Austria
Upcoming Conferences
International Conference and Exhibition on Addiction Research & Therapy , will be organized around the theme "New Treatment Aspects for Addiction".
Addiction Therapy-2012 is comprised of 10 tracks and 61 designed to offer comprehensive sessions that address current issues in Addiction Research & Therapy.
Submit your Abstract to any of the following Tracks.
Register now for the conference by choosing an appropriate package suitable to you.
Renowned Speakers
Yair Amram
Hebrew University of Jerusalem, Israel, Israel
Dannon Pinhas
Tel Aviv University, Israel
Fumihiro Imai
Ichiriyama Imai Clinic, Japan
Chaturaka Rodrigo
University of Colombo, Srilanka
José Miguel Chatkin
Pontificia Universidade Católica Rio Grande do Sul, Brazil
Ignacio Vázquez Moliní
European Monitoring Centre for Drugs and Drug Addiction, Portugal
Serge Ahmed
Université de Bordeaux, France
Danuta Chessor
University of Western Sydney, Australia
Lynne Dawkins
University of East London, UK
Christopher V Dayas
University of Newcastle, Australia
Jhodie R. Duncan
University of Melbourne, Australia
Julaine Allan
The Lyndon Community, Australia
Marc A. Lindberg
Marshall University, USA
Paul Frenger
A Working Hypothesis Inc., USA
Neil Paterson
Psychogenics Inc., USA
Arthur Horton
Lewis University, USA
Carolyn Heckman
Fox Chase Cancer Center, USA
Dorit Ron
University of California San Francisco, USA
Mark Schwartz
Castlewood Treatment Center, USA
M. Foster Olive
Arizona State University, USA
Philip K. Liu
Harvard Medical School, USA
Pierrie Guertin
Laval University, Canada
Lynda Poirier
University of Sherbrooke, Canada
Kenneth Blum
University of Florida College of Medicine, USA
Matthew Howard
University of North Carolina at Chapel Hill, USA
Andrey E. Ryabinin
Oregon Health & Science University, USA
Madhusudhanan Narasimhan
TTUHSC, USA
Douglas Braun-Harvey
The Sexual Dependency Institute of San Diego, USA
Jean Zwiller
Université de Strasbourg, France
Catherine Comiskey
Trinity College Dublin, Ireland
Marta Miquel
Jaume I University, Spain
Track 1: New Therapeutic Aspects for Addiction
Track 1-1
Brain-scanning technology
Track 1-2
Brain abnormalities in drug and alcohol addicts
Track 1-3
Ethical aspects in substance abuse treatment
Track 1-4
Substance abuse treatment
Track 1-5
Consequences of drug abuse
Track 1-6
Behavioral effects of drug abuse
Track 1-7
Adaptive changes in the brain due to drug abuse
Track 1-8
Global changes in metabolism and blood flow in brain
Track 1-9
Participation of transcription factors in neurodegeneration
Track 2: Current Research on Addiction
Track 2-1
Neuropsychopharmacology research
Track 2-2
Psychological stress and treatment studies
Track 2-3
Pharmacogenetics of drug dependence
Track 2-4
Brain-derived neurotrophic factor signaling
Track 2-5
Impulse-regulating brain networks and drug addiction in teenagers
Track 2-6
Brain-computer interfaces (BCI)
Track 2-7
Transcranial magnetic stimulation (TMS)
Track 2-8
Cohort studies
Track 3: Drug Addiction and Neurotoxicology
Track 3-1
Functional neurotoxicity of drugs
Track 3-2
Dysregulation of neural systems
Track 3-3
Neurobiology of drug addiction
Track 3-4
Neuroscience research on drug addiction
Track 4: Addiction Case Reports
Track 4-1
Neuronal disturbances
Track 4-2
Tourette's syndrome
Track 4-3
Alzheimer's disease
Track 4-4
Insomnia
Track 4-5
Cocaine-related disorders
Track 5: Various Addictives and Addictions
Track 5-1
Behavior addiction and pathological gambling
Track 5-2
Substance addiction: Alcohol, tobacco and cannabis
Track 5-3
Prescription drug abuse-Hypnotics/sedatives, opioids
Track 5-4
Central stimulants-Khat, methamphetamine
Track 5-5
Designer drugs
Track 5-6
Pornography and internet addiction
Track 6: Alcoholism and Therapy
Track 6-1
Genetic predisposition of alcoholism
Track 6-2
Psychological and sociological aspects of alcoholism
Track 6-3
Fetal alcohol syndrome
Track 6-4
Alcohol detoxification using chemotherapeutic agents
Track 6-5
Psychological and spiritual counseling
Track 7: Cocaine Addiction and Therapy
Track 7-1
Prenatal cocaine exposure
Track 7-2
Effects associated with cocaine
Track 7-3
Cocaine dependence
Track 7-4
Cocaine sensitization
Track 7-5
Selective dopamine stimulation in therapy
Track 7-6
Cognitive behavioral therapy for cocaine
Track 7-7
Brain imaging studies of cocaine
Track 8: Treatment and Rehabilitation using Various Therapies
Track 8-1
Pharmacotherapy
Track 8-2
Maintenance treatment
Track 8-3
Naltrexone treatment
Track 8-4
Heroin prescription
Track 8-5
Twelve step groups
Track 8-6
Cognitive behavioral therapy
Track 8-7
Yoga and physical therapy
Track 8-8
Counseling-Motivational, psychological, behavioral and coercive treatment through therapeutic communities
Track 9: Drug Addiction and Gene Therapy
Track 9-1
Motivational enhancement therapies
Track 9-2
Gene-silencing in dopaminergic neurons
Track 9-3
SiRNA for therapy of drug addiction and other brain diseases
Track 9-4
Applied nanotechnology to therapeutic concepts
Track 9-5
Drug delivery to treat addiction disorders
Track 10: Addiction Biology
Track 10-1
Epigenetic mechanisms related to addiction
Track 10-2
Inherited biological factors contributing to substance abuse and drug addiction
Track 10-3
Biochemical assays for alcoholism
Track 10-4
Genetic linkage studies